Skip to content
Search

Latest Stories

UK officials publish "priority pathogen" watch list

 UK priority pathogen watch list for public health safety.

Researchers hope the list will speed up vaccine and diagnostics development

Pic credit: iStock

UK officials published a watch list of 24 "priority pathogen" families on Tuesday, hoping to boost readiness in case another public health crisis strikes.

The UK Health Security Agency's guide is designed to help researchers focus their efforts on certain viruses and bacteria that pose a threat to public health, as well as speed up the development of vaccines.


Pathogen families on the list include coronaviridae, which includes Covid-19, paramyxoviridae, which includes Nipah virus, and orthomyxoviridae, which includes bird flu. Ebola, norovirus and mpox are also listed.

The agency's chief scientific officer Isabel Oliver said it was "a vital guide for industry and academia, highlighting where scientific research can be targeted to boost UK preparedness against health threats."

"We hope this will help to speed up vaccine and diagnostics development where it is most needed, to ensure we are fully prepared in our fight against potentially deadly pathogens."

Five years since the start of the global Covid-19 pandemic, emotions still run raw across the UK with lingering accusations that the then government responded too slowly to the crisis.

According to the WHO, more than 232,000 people have died with Covid in the United Kingdom.

More For You

Swanley Pharmacy in Kent

Swanley Pharmacy in Kent

First-time buyers swoop in for Allcures Plc's Swanley Pharmacy

A husband and wife couple have embarked on their journey as first time pharmacy owners after buying Swanley Pharmacy in Kent.

Located in Swanley Shopping Centre, the pharmacy dispenses an average of 10,000 items per month.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less